Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules

  • Authors:
    • Dan Ilkovitch
    • Laura K. Ferris
  • View Affiliations

  • Published online on: August 26, 2016     https://doi.org/10.3892/mmr.2016.5685
  • Pages: 3935-3940
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Psoriasis is a debilitating chronic inflammatory disease. In addition to the characteristic effects on the skin, chronic inflammation associated with the disease is recognized to contribute to cardiovascular, hepatic and renal comorbidities. Immature myeloid regulatory cells, known as myeloid‑derived suppressor cells (MDSCs), have been demonstrated to accumulate in various diseases and chronic inflammatory states, including inflammatory bowel disease and various types of cancer. The results of the present study, obtained using flow cytometry and cell culture analysis of peripheral blood mononuclear cells from psoriasis and healthy patients, revealed that MDSC levels are significantly increased in the blood of patients with psoriasis compared with healthy controls. Furthermore, these cells are capable of producing various molecules, including matrix metalloproteinase‑9 and‑1, interleukin‑8, growth‑related oncogene, and monocyte chemoattractant protein 1. These molecules may recruit additional immune cells involved in the pathogenesis of the disease, and contribute to the chronic inflammatory state in these patients. Therefore, MDSCs, which have various immune regulatory functions, may contribute to the pathogenesis of psoriasis as a systemic inflammatory disease.
View Figures
View References

Related Articles

Journal Cover

October-2016
Volume 14 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ilkovitch D and Ilkovitch D: Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep 14: 3935-3940, 2016
APA
Ilkovitch, D., & Ilkovitch, D. (2016). Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Molecular Medicine Reports, 14, 3935-3940. https://doi.org/10.3892/mmr.2016.5685
MLA
Ilkovitch, D., Ferris, L. K."Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules". Molecular Medicine Reports 14.4 (2016): 3935-3940.
Chicago
Ilkovitch, D., Ferris, L. K."Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules". Molecular Medicine Reports 14, no. 4 (2016): 3935-3940. https://doi.org/10.3892/mmr.2016.5685